Thermo Fisher Scientific Inc. Share Price
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
610.49 USD | -0.60% | -2.20% | +15.02% |
16/09 | Thermo Fisher Likely to Update Growth Plan, Focus on Business Lines, Services, UBS Says | MT |
16/09 | UBS Raises Thermo Fisher Scientific Price Target to $700 From $670, Maintains Buy Rating | MT |
Capitalization | 23TCr 19,51300Cr | P/E ratio 2024 * |
37.9x | P/E ratio 2025 * | 33.2x |
---|---|---|---|---|---|
Enterprise value | 23TCr 19,40600Cr | EV / Sales 2024 * |
6x | EV / Sales 2025 * | 5.54x |
Free-Float |
86.05% | Yield 2024 * |
0.24% | Yield 2025 * | 0.26% |
Last Transcript: Thermo Fisher Scientific Inc.
1 day | -0.60% | ||
1 week | -2.20% | ||
Current month | -0.74% | ||
1 month | +1.08% | ||
3 months | +7.48% | ||
6 months | +4.51% | ||
Current year | +15.02% |
Director | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01/01/01 |
Director of Finance/CFO | 57 | 01/01/01 | |
Sebastian Pacios
CTO | Chief Tech/Sci/R&D Officer | - | 01/23/01 |
Manager | Title | Age | Since |
---|---|---|---|
Scott Sperling
BRD | Director/Board Member | 66 | 09/06/09 |
Marc Casper
CEO | Chief Executive Officer | 56 | 01/01/01 |
Tyler Jacks
BRD | Director/Board Member | 63 | 26/09/26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
11.69% | 2 M€ | -25.75% | ||
7.43% | 18 M€ | +10.12% | - | |
5.37% | 2 M€ | -.--% |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-0.60% | -2.20% | +18.42% | +2.29% | 23TCr | ||
-1.29% | -0.82% | +6.75% | -16.04% | 20TCr | ||
-1.64% | -0.19% | +63.54% | +39.79% | 17TCr | ||
-1.19% | -0.65% | +55.99% | +85.98% | 12TCr | ||
-0.35% | -0.60% | +10.01% | -13.84% | 6.2TCr | ||
-3.07% | +0.13% | -8.16% | -43.70% | 4.05TCr | ||
+0.03% | +0.23% | +19.36% | -20.46% | 3.98TCr | ||
+0.17% | +1.45% | +30.65% | - | 3.96TCr | ||
-0.20% | -4.31% | -16.42% | -29.48% | 3.95TCr | ||
-0.35% | -0.78% | +72.56% | -12.26% | 3.69TCr | ||
Average | -0.54% | -0.44% | +25.27% | -0.86% | 9.82TCr | |
Weighted average by Cap. | -0.51% | -0.51% | +28.16% | +10.19% |
2024 * | 2025 * | |
---|---|---|
Net sales | 4.29TCr 3,59100Cr | 4.55TCr 3,81100Cr |
Net income | 614.18Cr 51TCr | 692.51Cr 58TCr |
Net Debt | 2.41TCr 2,02000Cr | 1.93TCr 1,61800Cr |
Date | Price | Change | Volume |
---|---|---|---|
17/24/17 | 610.49 $ | -0.60% | 1,333,012 |
16/24/16 | 614.15 $ | +0.49% | 1,198,221 |
13/24/13 | 611.17 $ | -0.49% | 1,125,097 |
12/24/12 | 614.16 $ | -0.70% | 1,397,629 |
11/24/11 | 618.46 $ | -0.92% | 1,324,098 |
Delayed Quote Nyse, September 18, 2024 at 01:30 am IST
More quotes- Stock Market
- Equities
- TMO Stock
MarketScreener is also available in this country: United States.
Switch edition